These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9456194)

  • 1. Effect of long-term beta2-agonist dosing on human cardiac beta-adrenoceptor expression in vivo: comparison with changes in lung and mononuclear leukocyte beta-receptors.
    Qing F; Rahman SU; Hayes MJ; Rhodes CG; Ind PW; Jones T; Hughes JM
    J Nucl Cardiol; 1997; 4(6):532-8. PubMed ID: 9456194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo quantification of human pulmonary beta-adrenoceptors: effect of beta-agonist therapy.
    Hayes MJ; Qing F; Rhodes CG; Rahman SU; Ind PW; Sriskandan S; Jones T; Hughes JM
    Am J Respir Crit Care Med; 1996 Nov; 154(5):1277-83. PubMed ID: 8912736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta 2-adrenoceptors in human lung and peripheral mononuclear leukocytes of untreated and terbutaline-treated patients.
    Hauck RW; Böhm M; Gengenbach S; Sunder-Plassmann L; Fruhmann G; Erdmann E
    Chest; 1990 Aug; 98(2):376-81. PubMed ID: 1973910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic effects of inhaled albuterol on beta-adrenoceptor system function in human respiratory cells.
    Kelsen SG; Aksoy MO; Brennan K; Ciccolella D; Borbely B
    J Asthma; 2000 Jun; 37(4):361-70. PubMed ID: 10883747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo quantification of human pulmonary beta-adrenoceptor density using PET: comparison with in vitro radioligand binding.
    Qing F; Rhodes CG; Hayes MJ; Krausz T; Fountain SW; Jones T; Hughes JM
    J Nucl Med; 1996 Aug; 37(8):1275-81. PubMed ID: 8708755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist-induced beta-adrenergic receptor internalization on intact human mononuclear leukocytes: effect of temperature of mononuclear leukocyte separation.
    De Blasi A; Cotecchia S; Fratelli M; Lipartiti M
    J Lab Clin Med; 1986 Jan; 107(1):86-94. PubMed ID: 2867118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo quantification of pulmonary beta-adrenoceptor density in humans with (S)-[11C]CGP-12177 and PET.
    Ueki J; Rhodes CG; Hughes JM; De Silva R; Lefroy DC; Ind PW; Qing F; Brady F; Luthra SK; Steel CJ
    J Appl Physiol (1985); 1993 Aug; 75(2):559-65. PubMed ID: 7901192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of pulmonary and myocardial beta-adrenoceptors with S-1'-[fluorine-18]fluorocarazolol.
    Visser TJ; van Waarde A; van der Mark TW; Kraan J; Elsinga PH; Pruim J; Ensing K; Jansen T; Willemsen AT; Franssen EJ; Visser GM; Paans AM; Vaalburg W
    J Nucl Med; 1997 Feb; 38(2):169-74. PubMed ID: 9025729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characteristics of BDTI, a new isoquinoline-derived beta 2-adrenoceptor agonist, in canine trachea and rat heart.
    Lin CH; Yang CM; Chen CM; Ko FN; Teng CM
    Pharmacology; 1996 Jul; 53(1):19-27. PubMed ID: 8875598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods.
    Silke B; Hanratty CG; Riddell JG
    J Cardiovasc Pharmacol; 1999 Jun; 33(6):859-67. PubMed ID: 10367588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does treatment with beta-adrenergic blocking agents cause a decrease in beta 2-adrenoceptor affinity?
    Blankesteijn WM; Graafsma SJ; Hectors MP; Olde Riekerink EA; Rodrigues de Miranda JF; Thien T
    Eur J Clin Pharmacol; 1992; 42(6):613-8. PubMed ID: 1352497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of beta 2-agonist- and dexamethasone-treatment on relaxation and regulation of beta-adrenoceptors in human bronchi and lung tissue.
    Hauck RW; Harth M; Schulz C; Präuer H; Böhm M; Schömig A
    Br J Pharmacol; 1997 Aug; 121(8):1523-30. PubMed ID: 9283684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of receptor reserve on beta-adrenoceptor-mediated responses in human lung mast cells.
    Drury DE; Chong LK; Ghahramani P; Peachell PT
    Br J Pharmacol; 1998 Jun; 124(4):711-8. PubMed ID: 9690863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.
    Ryall JG; Sillence MN; Lynch GS
    Br J Pharmacol; 2006 Mar; 147(6):587-95. PubMed ID: 16432501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trachea relaxing effects and beta2-selectivity of SPFF, a newly developed bronchodilating agent, in guinea pigs and rabbits.
    Gan LL; Wang MW; Cheng MS; Pan L
    Biol Pharm Bull; 2003 Mar; 26(3):323-8. PubMed ID: 12612441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
    Aziz I; Lipworth BJ
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of β
    Mori A; Sekito A; Sakamoto K; Ishii K; Nakahara T
    Naunyn Schmiedebergs Arch Pharmacol; 2017 May; 390(5):527-533. PubMed ID: 28160015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
    Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H
    Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-induced β2-adrenoceptor desensitization and downregulation enhance pro-inflammatory cytokine release in human bronchial epithelial cells.
    Oehme S; Mittag A; Schrödl W; Tarnok A; Nieber K; Abraham G
    Pulm Pharmacol Ther; 2015 Feb; 30():110-20. PubMed ID: 24915152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.